Premarket today is being shaped by two forces pulling in opposite directions.

Geopolitical developments around Iran are unwinding trades that had been running hot since the conflict began. On the other side, earnings and corporate news are driving sharp moves higher: a software company reported stronger-than-expected results, a chip designer made a major statement about its revenue ambitions, and a buyout locked in gains for one biopharma name.

The thread connecting this morning's action is that the market is rewarding clarity and punishing uncertainty. Companies that met the bar and told investors to expect more are being lifted; those that missed or signaled caution are drifting lower before the open.

Every modern rocket engine relies on extreme-performance materials. But there’s a limited global supply supporting a rapidly expanding space industry.

Read the full report to see why it matters… and which player might matter most.

Braze (BRZE): +20%

The customer engagement software company blew past revenue estimates, and the market is rewarding it accordingly. The management’s forward guidance for revenue also came in above what the Street was expecting, which sent the stock sharply higher in premarket.

Arm (ARM): +12%

The chip design company unveiled its first in-house chip and dropped a revenue target for 2031 that landed well above what analysts were modeling. Arm has been a beneficiary of the AI infrastructure buildout, and this move signals it wants a bigger piece of that economics directly, not just through licensing.

EchoStar (SATS): +6%

The satellite communications company is catching a lift from a report that SpaceX could file for an IPO as soon as this week. EchoStar holds a stake in the Elon Musk-led company, making it one of the few publicly traded ways to get indirect exposure to a potential SpaceX listing.

Terns Pharmaceuticals (TERN): +6%

Merck agreed to buy the biopharma company for $53 per share in an all-cash deal worth roughly $6.7 billion. The premium to Tuesday's close is modest, but an all-cash acquisition at a named price tends to lock in gains.

CF Industries (CF): -4%

Reports suggesting U.S.-Iran war negotiations are progressing hit the fertilizer manufacturer hard. CF’s stock has surged since the conflict began, riding the commodity shortage driven by Strait of Hormuz disruptions. If a deal comes together, the supply picture changes fast, and the trade unwinds just as quickly.

KB Home (KBH): -2%

The homebuilder missed on both earnings and revenue in its fiscal first quarter, then added a weak forward outlook on housing revenue and deliveries. In a rate-sensitive sector where buyers are already stretched, missing on the numbers and guiding light is a combination the market doesn't forgive easily.

Micron (MU): -1%

SK Hynix's plan to raise up to $10 billion via a potential U.S. listing is rattling Micron shareholders. An SK Hynix listing would give American investors direct access to a rival that currently trades at a lower valuation, which could pull capital away from Micron.

Every modern rocket engine relies on extreme-performance materials. But there’s a limited global supply supporting a rapidly expanding space industry.

Read the full report to see why it matters… and which player might matter most.

The Mosaic Company (MOS)

While CF Industries has grabbed the headlines in the fertilizer trade, retail traders on r/wallstreetbets are building a separate case for Mosaic as the sector's sleeper play. The argument is that oil gets the attention, but phosphate and potash, which Mosaic specializes in, could be the second-order disruption. Roughly a third of global fertilizer production and logistics runs through the Hormuz region, and physical shortages tend to show up in Mosaic's markets with a lag.

Mosaic is down about 6% over the past month, even as CF soared, which is what's driving the curiosity. The question traders are circling is whether that divergence closes, or whether the market keeps the stock in the penalty box even if fertilizer prices stay elevated.

✌️That’s it for today.